Farther Finance Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Sell
2,003
-356
-15% -$19.2K ﹤0.01% 2476
2026
Q1
$126K Buy
2,359
+95
+4% +$5.7K ﹤0.01% 2336
2025
Q4
$133K Buy
2,264
+381
+20% +$23.1K ﹤0.01% 2168
2025
Q3
$105K Buy
1,883
+198
+12% +$10.6K ﹤0.01% 2014
2025
Q2
$86.7K Buy
1,685
+61
+4% +$3.06K ﹤0.01% 1831
2025
Q1
$93.1K Sell
1,624
-5,035
-76% -$341K ﹤0.01% 1580
2024
Q4
$480K Buy
6,659
+37
+0.6% +$2.72K 0.02% 604
2024
Q3
$529K Buy
6,622
+91
+1% +$6.84K 0.02% 569
2024
Q2
$468K Sell
6,531
-3,254
-33% -$239K 0.02% 503
2024
Q1
$679K Buy
9,785
+9,604
+5,306% +$687K 0.04% 324
2023
Q4
$14K Buy
181
+144
+389% +$9.48K ﹤0.01% 1460
2023
Q3
$2.52K Sell
37
-2
-5% -$158 ﹤0.01% 1767
2023
Q2
$3.18K Buy
39
+7
+22% +$563 ﹤0.01% 1595
2023
Q1
$2.37K Hold
32
﹤0.01% 1577
2022
Q4
$2.65K Buy
+32
New +$2.54K ﹤0.01% 1355

Other funds holding TECH

Farther Finance Advisors's TECH Position: Q2 2026 in Review

Farther Finance Advisors reduced its Bio-Techne (TECH) stake by 15% in Q2 2026, selling an estimated $19.2K and leaving 2,003 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2476.

Farther Finance Advisors first reported a position in TECH in Q4 2022 and has held it in 15 quarters since. The position peaked at $679K in Q1 2024. 82 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Farther Finance Advisors held 2,003 shares of Bio-Techne worth $142K as of Q2 2026.
  • Farther Finance Advisors sold 356 Bio-Techne shares in Q2 2026, an estimated $19.2K.
  • Bio-Techne made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2476 holding.
  • Farther Finance Advisors first reported a position in Bio-Techne in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Bio-Techne position peaked at $679K in Q1 2024.
  • 82 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.